
    
      Anlotibib (AL3818) is a kind of innovative medicines approved by State Food and Drug
      Administration（SFDA:2011L00661） which was researched by Jiangsu Chia-tai Tianqing
      Pharmaceutical Co., Ltd.To compare the effects and safety of Anlotinib with placebo in
      patients with metastatic colorectal cancer refractory to standard chemotherapies.
    
  